American Bio Medica Corporation (ABMC)
Company Description
American Bio Medica Corporation engages in manufacture and sale of lateral flow immunoassay tests primarily for the immediate detection of drugs in urine and oral fluids.
Its drugs detection products in urine include Rapid Drug Screen, a rapid drug test, which detects the presence or absence of 2 to 10 drugs; RDS InCup, a drug-testing cup that detects the presence or absence of 1 to 12 drugs; Rapid TOX, a drug test in a cassette platform, which detects the presence or absence of 1 to 10 drugs; and Rapid TOX Cup II, a drug testing cup that detects the presence or absence of 1 to 16 drugs.
The company also offers a test for the detection of respiratory syncytial virus; OralStat, a drug test for the detection of drugs in oral fluids, as well as private labeled versions of OralStat.
In addition, the company distributes other products for the detection of substances of abuse, as well as products to detect certain infectious diseases.
Further, it provides strip contract manufacturing, assembly, and packaging services to unaffiliated diagnostic companies.
The company serves rehabilitation/drug treatment, pain management, other clinical, government, and employment/workplace markets.
It operates in the United States, North America, Europe, the Asia Pacific, and South America. The company was formerly known as American Micro Media, Inc. and changed its name to American Bio Medica Corporation in September 1992.
American Bio Medica Corporation was incorporated in 1986 and is based in Kinderhook, New York.
Country | NY |
Founded | 1986 |
IPO Date | Dec 24, 1997 |
Industry | Diagnostics & Research |
Sector | Healthcare |
Employees | 16 |
CEO | Ms. Jean Neff |
Contact Details
Address: 122 Smith Road Kinderhook, New York 12106 United States | |
Phone | 5187588158 |
Website | abmc.com |
Stock Details
Ticker Symbol | ABMC |
Exchange | OTCMKTS |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0000896747 |
CUSIP Number | 024600108 |
ISIN Number | US0246001087 |
Employer ID | 14-1702188 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Jean Neff | Corporate Secretary and Independent Director |
J. Duncan Urquhart | Controller |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Jun 12, 2023 | 10-Q | Quarterly Report |
May 15, 2023 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB |
Mar 21, 2023 | 10-K | Annual Report |
Mar 1, 2023 | 8-K | Current Report |
Feb 17, 2023 | 8-K | Current Report |
Jan 11, 2023 | DEF 14A | Other definitive proxy statements |
Jan 5, 2023 | PRER14A | Filing |
Dec 22, 2022 | PRE 14A | Other preliminary proxy statements |
Dec 21, 2022 | 8-K | Current Report |
Nov 16, 2022 | 10-Q | Quarterly Report |